Pharma, Medtech, and Biotech: Regulatory Updates, AI Risks, & Enforcement Trends

November 12, 2026

Gardner Law event banner
Agenda
1:00–1:30 P.M. PT | OPENING BRIEFINGS
Hot Topics in Regulatory, Privacy, and Compliance
Timely opening briefings from Nathan Downing, Amanda Johnston, and Paul Rothermel.
BUILD   |   1:30–2:10 p.m. PT
Regulatory strategy, evidence, and product decisions
How companies navigate FDA and EU regulatory requirements, anticipate challenges, minimize risk, and make informed decisions throughout the product lifecycle.
Headshot of Nathan Downing
MODERATOR
Nathan Downing
Gardner Law
Managing Attorney
Headshot of Dr. Cord Willhöft
Dr. Cord Willhöft
Fieldfisher
Partner, Co-Head, Life Sciences & Healthcare
Headshot of Alex Vayser
Alex Vayser
Concur Biophotonics / Videra Surgical
Founder & CEO
Headshot of Jeffrey Lau
Jeffrey Lau
Glaukos
Associate General Counsel
LAUNCH   |   2:10–2:50 p.m. PT
Commercialization and marketplace risk
How companies can commercialize products while managing the risks that arise when products, data, patients, providers, and field teams begin interacting in the marketplace.
Headshot of Paul Rothermel
MODERATOR
Paul Rothermel
Gardner Law
Managing Attorney
Headshot of Sameena Habib
Sameena Habib
Medtronic
Global R&D AI & Data Counsel
Headshot of Chase Leavitt
Chase Leavitt
Mobia Medical
General Counsel
Headshot of Brian Kelly
Brian Kelly
Advanced Bionics
VP, Chief Compliance Officer
GROW   |   3:05–3:45 p.m. PT
Managing a more complex compliance environment
How companies navigate evolving enforcement priorities and healthcare fraud risks through auditing, monitoring, and compliance controls as promotional activities and commercial programs expand.
Headshot of Amanda Johnston
MODERATOR
Amanda Johnston
Gardner Law
Partner
Headshot of Shannon Treviño
Shannon Treviño
SpyGlass Pharma
General Counsel
Headshot of Karyl Haskell
Karyl Haskell
OrthAlign
VP, Regulatory Affairs & Quality Assurance
Headshot of Liana Edgar
Liana Edgar
HeartFlow
Corporate Counsel
ASK THE EXPERTS   |   3:45–4:15 p.m. PT
Questions for industry counsel
Bring your regulatory, privacy, and compliance questions to an interactive discussion.
Headshot of Mark Gardner
MODERATOR
Mark Gardner
Gardner Law
Founder & Managing Partner
Headshot of Melissa Hoffman
Melissa Hoffman
Edwards Lifesciences
VP, Lead Counsel, TMTT
Headshot of Christopher Shurland
Christopher Shurland
Asahi Intecc USA
Managing Counsel
Headshot of Sara Kerrane
Sara Kerrane
Glaukos
VP, IP, Regulatory & Litigation Counsel
Join from anywhere. Connect in Newport Beach.
In-person attendees are invited to the networking reception immediately following the program.
Register Here

Program Details

1:00–1:30 p.m. PT

Hot Topics in Regulatory, Privacy, and Compliance

Gardner Law Attorneys Nathan Downing, Paul Rothermel, and Amanda Johnston will open the program with three 10-minute briefings on timely regulatory, privacy, and compliance developments affecting medical products companies and their implications for legal and business priorities.

1:30–2:10 p.m. PT

Build:
Regulatory strategy, evidence, and product decisions

Moderator: Nathan Downing

Panelists: Dr. Cord Willhöft (Partner, Co-Head of Life Sciences & Healthcare, Fieldfisher), Alex Vayser (Founder, CEO, Concur Biophotonics & Founder, Videra Surgical), and Jeff Lau (Associate General Counsel, Glaukos)

Panelists will examine how companies navigate FDA and EU regulatory requirements, develop clinical evidence, and align product claims with intended use. The discussion will also address how data governance, privacy, cybersecurity, and early compliance decisions affect regulatory risk, commercialization, and investment or acquisition diligence.

2:10–2:50 p.m. PT

Launch:
Commercialization and marketplace risk

Moderator: Paul Rothermel

Panelists: Sameena Habib (Global R&D AI & Data Counsel, Medtronic), Chase Leavitt (General Counsel, Mobia Medical), and Brian Kelly (VP, Chief Compliance Officer, Advanced Bionics)

This panel will explore legal and operational risks associated with developing and commercializing AI-enabled technologies, evolving privacy requirements, promotional claims, reimbursement, and patient engagement. Panelists will also discuss managing data collection, sales practices, vendor oversight, and coordination across legal and business functions.

2:50–3:05 p.m. PT

Refreshment Break

3:05–3:45 p.m. PT

Grow:
Managing a more complex compliance environment

Moderator: Amanda Johnston

Panelists: Shannon Treviño (General Counsel, SpyGlass Pharma), Karyl Haskell (VP Regulatory Affairs and Quality Assurance, Orthalign), and Liana Edgar (Corporate Counsel, Heartflow)

As companies expand their products, markets, and commercial activities, regulatory and compliance obligations become increasingly complex. Panelists will discuss government enforcement priorities, healthcare fraud risks, internal investigations, and practical approaches to strengthening compliance programs through auditing, monitoring, third-party oversight, and internal controls.

3:45–4:15 p.m. PT

Ask the Experts: Regulatory, Privacy, and Compliance Q&A

Moderator: Mark Gardner

Panelists: Melissa Hoffman (Vice President, Lead Counsel: TMTT, Edwards Lifesciences), Christopher Shurland (Managing Counsel, Asahi Intecc USA), and Sara Kerrane (Vice President, Intellectual Property, Regulatory and Litigation Counsel, Glaukos Corporation)

The program will conclude with an interactive Q&A moderated by Mark Gardner. In-person and livestream attendees can submit questions to senior in-house attorneys about regulatory strategy, privacy, compliance, enforcement, and other legal and operational challenges facing medical products companies.

4:15 p.m. PT

Networking Reception

Certifications

The program has been submitted for approval for 3 CLE credits with the Minnesota and California State Bars and 3 RAC certification credits with the Regulatory Affairs Professional Society.

Contact

For questions about registration, livestream access, or continuing education credit, please email office@gardner.law.